H1N1 2009

H1N1 Fact Sheet | Pandemic Preparedness

H1N1 and Global Health

The Strategic Power of Vaccines

The second CSIS High-Level Forum on U.S. Leadership in Global Health placed a focus on vaccines as instruments of U.S. global leadership in pursuit of security and economic interests at home and abroad, in close enduring partnerships with corporations, foundations, multilateral organizations, and other countries.

The event opened with a screening of the extended trailer of The Strategic Power of Vaccines in Zambia, a piece that aims to portray the complexities of immunization in Zambia and to make broader points about global immunization efforts. The five minute trailer is a preview of a longer piece that will be completed in early 2012.

At the conference, the CSIS Global Health Policy Center released two reports centered on vaccines. 

Role(s) of Vaccines and Immunization Programs in Global Disease Control

Given the relative successes of the GAVI Alliance (formerly, the Global Alliance for Vaccines and Immunisation) and the recent call by the World Health Assembly for a global vaccine action plan to guide the world for the next 10 years, the world is focusing much attention, justifiably, on various aspects of macropolicy and planning for the progressive expansion of global vaccine efforts.  This brief report focuses on the “nuts and bolts” of the complex biological, epidemiologic, and risk management concepts that are the foundations of global and national “expert group” recommendations for specific target groups for currently available childhood vaccines and others. Using examples of specific vaccine successes and disease challenges, this report highlights the ongoing attention to detail required for the success of local, national, and global immunization efforts.

The Future of Global Immunization

In January 2010 at the World Economic Forum, the Bill and Melinda Gates Foundation launched the Decade of Vaccines by pledging $10 billion over the next 10 years to support worldwide efforts to develop and deliver vaccines to the world’s poorest countries. The foundation also challenged other global partners to demonstrate their continuing commitment and, in so doing, to dramatically reduce child mortality by the end of the decade. This is a tremendous opportunity for transforming global health and could have significant consequences for child survival while expanding the impact of vaccines across the lifespan, but there is no easy formula for success. How a number of challenges are addressed will be critical to success or failure in the next decade and to the most effective use of available resources. This report outlines 10 important issues facing the global vaccine and immunization agenda.

Event Multimedia

Following the video about Zambia, there were two keynote address and three panel discussions that focused on (1) vaccinology in the 21st century; (2) the private sector; (3) obstacles to immunization efforts; (4) vaccines and security; and (5) U.S. leadership in global immunization.

Part 1: CSIS Senior Vice President and Director of the Global Health Policy Center, J. Stephen Morrison, offers introductory remarks.  Following his remarks and a short video, Anthony Fauci, Director of the National Institute of Allergies and Infectious Diseases at the National Institutes of Health, gave a keynote address entitled - Vaccinology: Considerations for the 21st century.

Listen to audio from Part 1.

Part 2: J. Stephen Morrison discussed the importance of a robust private sector for the future of vaccines with panelists Julie Gerberding of Merck & Co.; Margaret McGlynn of the International AIDS Vaccine Initiative; and Regina Rabinovich of the Bill & Melinda Gates Foundation.

Listen to audio from Part 2.

Part 3: Amanda Glassman of the Center for Global Development moderated a discussion about overcoming obstacles to immunization efforts with panelists Helen Evans of the GAVI Alliance; Orin Levine of Johns Hopkins University; and Anne Schuchat of the Centers for Disease Control and Prevention (CDC).

Listen to audio from Part 3.

   Download Helen Evans presentation.

Part 4: Admiral William Fallon led the final panel of the day for a dialogue on vaccines and security with panelists Stephen Cochi of CDC; Markus Geisser of the International Committee of the Red Cross; and Eric Schwartz of the Humphrey School at the University of Minnesota.

Listen to audio from Part 4.

Part 5: Dr. Rajiv Shah of USAID gives the second keynote address of the event on U.S. Leadership in Global Immunization.  Dr. Shah's keynote is followed by a brief Q & A with J. Stephen Morrison.

Listen to audio from Part 5.

Related Content

Emerging Practices in Global Health Cooperation

On December 6th the CSIS Global Health Policy Center hosted a half-day conference on “Emerging Practices in Global Health Cooperation: Brazil, China, India, Russia and South Africa”. It featured panelists with expertise on the engagement of emerging economies, such as the BRICS, with international organizations, and through trilateral, regional and South-South cooperation schemes.

Over the past year, CSIS has worked with locally-based research centers in each of the BRICS to support shared research, facilitate discussion, and disseminate policy analysis to encourage greater understanding of the ways in which approaches to global health policy and cooperation are changing. Building on the outcomes of workshops held in Beijing, Moscow, Rio de Janeiro, and Johannesburg, the December 6 seminar will feature expert panelists whose presentations will highlight how each nation conceptualizes its current and future health outreach; identify new and evolving trends with respect to regional, South-South, and trilateral health cooperation; and articulate an agenda for future discussion and research.

Multimedia

Part 1: The Engagement of the BRICS with International Organizations 


During the first panel, Peter Fourie (AIDS Foundation of South Africa) focused on the role of South Africa within the BRICS community. South Africa officially joined the BRICS in March of 2011. While questioning the appropriateness of South Africa’s membership in the BRICS community, noting that in many ways it is an economic, geographic and demographic outlier, Fourie discussed the relevance of South African participation in setting an agenda for global health cooperation within the BRICS context. He emphasized the ideological similarities among the BRICS, and the valuable use of health as a means to project soft power in the multilateral arena.

Yanzhong Huang (Council on Foreign Relations and Seton Hall University) elaborated on the involvement of the BRICS in global health activities. He suggested that some of the BRICS, such as China, engage in global health policy and programmatic efforts to demonstrate that they are responsible international stakeholders, able and willing to respect international rules and adopt a normative multilateral approach to global health governance.

Julia Kulik (University of Toronto) examined the history of health challenges in Russia, with a focus on the country’s growing burden of non-communicable diseases. She highlighted the opportunity Russia has to display international leadership on NCDs as host of the 2012 APEC Summit, the 2013 G20 Summit, and the 2014 G8 and BRICS Summits.

Listen to audio from Part 1.

Download Peter Fourie's presentation.

  Download Julia Kulik's presentation.


Part 2: Regional Interactions and Trilateral/Regional/South-South Cooperation 


In the second panel, Priya Balasubramaniam (Public Health Foundation of India) emphasized the potential for health investments in India to serve as a driver for economic development. She described India’s move toward universal health coverage as a means of reducing poverty while increasing global leadership. She suggested that as India’s health system evolves, it has the opportunity to become a global leader in the movement toward worldwide universal health coverage, particularly given its similarities to other countries of the South in terms of disease dynamics, living conditions, health systems and its social, political, economic and geographic environment.

Jonathan Hale (Bureau of European and Eurasian Affairs, USAID) discussed U.S. and Russian collaboration on the eradication of polio in Central Asia through trilateral capacity-building exercises, technical cooperation, human resource training, and disaster preparedness planning.

Marian Jacobs (University of Cape Town) questioned the relevance of the BRICS, focusing instead on the shared democratic credentials, emerging economy status, potential for world engagement and rights framework of IBSA, which involves India, Brazil and South Africa in trilateral cooperation. She further emphasized the need for South-South cooperation for economic development.

Felix Rosenberg (Fiocruz) finished by highlighting the nexus between health and foreign policy, citing cooperation in global health as a diplomatic tool for driving national security strategies, and shaping geopolitics. He discussed some of Brazil’s the global health priorities that include: building strong national health systems and structures, creating horizontal partnerships between governments or government-linked civil society organizations to allow for joint learning and cooperation based on mutual trust and shared interests, strengthening ties between ‘affinity nations’ to improve the bilateral, and North-South-South trilateral, relationships within the larger multilateral governance space.

When the health ministers from the BRICS met for the first time in Beijing in July of 2011 they agreed to collaborate on advancing global health goals, but as the conference presentations suggest, the countries have diverse agendas and interests when it comes to global health cooperation. How will the BRICS work together to fulfill health-related promises? Are they poised to step up with more funds and commitment in light of the financial crises in Europe and U.S.? What are the opportunities for triangular cooperation in the future? The influence of the BRICS on global health will be determined by the response of each of the countries to these important challenges and questions.

Listen to audio from Part 2.

Download Priya Balasubramaniam's presentation.

Download Marian Jacob's presentation.

 

Part 3: Conclusions and Next Steps

 

J. Stephen Morrison, CSIS Global Health Policy Center
Katherine Bliss, CSIS Global Health Policy Center

Listen to audio from Part 3.

Related Publications

This report represents the first step in an 18-month CSIS initiative focused on how the BRIC (Brazil, Russia, India, and China) countries and South Africa are influencing activities, practices, and strategies in the area of global health diplomacy. Whether and how the BRICs and South Africa use the November 2010 G-20 Summit in Seoul, or future G-20 meetings, to engage on global health through the new G-20 Working Group on Development remains to be seen. It is clear that each country is stepping up its work on global health through its official development assistance—as a bilateral donor, through its work in multilateral institutions, and by supporting overseas health-related research and innovations. Yet it also seems unlikely that the non-G-8 countries within the G-20 will want to let the major industrial powers in the G-8 off the hook when it comes to their existing commitments on health in the developing world. In the end, how the BRICs and South Africa choose to move forward on global health will depend in large part on their own histories of international interaction on health, on their continued financial growth, and on the extent to which engaging in foreign activities does not conflict with their domestic health and development priorities.

 

This volume is a compilation of papers that were written for the Conference on China’s Emerging Global Health and Foreign Aid Engagement, sponsored by the Center for Strategic and International Studies (CSIS) and the China Institute of International Studies (CIIS), in Beijing on May 24, 2011, as part of a larger CSIS initiative to examine the global health engagement of the BRIC countries (Brazil, Russia, India, and China). Focusing specifically on China’s health and foreign aid engagement in Africa, the volume includes contributions by U.S. and Chinese experts.

 

 

Related Content

Health Reconstruction in Japan After 3-11

J. Stephen Morrison
Senior Vice President, CSIS & Director, Global Health Policy Center at CSIS

Since April 2011, I organized a health working group that has examined the complex, evolving health situation in Japan, post-March 11, and weighed what would be the most appropriate and effective U.S. assistance in the medium term to support Japanese-led health recovery efforts. That working group contributed the health chapter contained in a broader CSIS effort – the ‘Partnership for Recovery and a Stronger Future: Standing with Japan after 3-11,’ which today issued its final report here in Washington.

We built the health work on a preexisting partnership with the Health and Global Health Policy Institute (HGPI) in Japan which began in late 2009 with the aim of generating new analytic work on shared health reform challenges and actionable steps to address them.

In Chapter Four of the final report, entitled Health and Recovery, we identify three core issues that are most appropriate and effective for U.S. assistance over the next three years in support of Japanese-led reconstruction initiatives:

  • A focus on the health implications of long-term, low-dose radiation. The unfolding Japanese experience with radiation in Fukushima has a significance that extends well beyond Japan. It brings forward global health issues related to defining safety and scientific standards; steps to prepare for a crisis of this kind; and effective communications with the public.
  • Building back health infrastructure in a better, more integrated and cost-effective manner, including use of information technology.
  • The delivery of services to traumatized, aging and dislocated populations.

Download the report.

Please use the comment form below to provide feedback!

Related Content

Launch of CSIS Report on DoD Overseas Research Laboratories

By Youngji Jo

On June 28th, the CSIS Global Health Policy Center released the final report of its project on the Defense Department’s overseas medical research laboratories, which are important U.S. assets at the intersection of health and security. 

Despite their long and accomplished history, the Department of Defense (DOD) overseas medical research laboratories have been largely unknown and undervalued outside the research community. With this in mind, CSIS conducted a careful, yearlong independent analysis of the laboratories’ value, the challenges they face, and a vision for their future. The CSIS team based its report on meetings with D.C. experts as well as visits to DOD medical laboratories in Kenya, Egypt, Thailand, Cambodia, and Peru. 

The report is available here.

The report launch consisted of four parts: an introduction by Dr. John Hamre, President & CEO of CSIS; a summary of the report from Lieutenant General James Peake, U.S. Army (retired), with responses from the laboratory leadership; a panel discussion featuring partners of the laboratories; and a keynote address from Dr. Jonathan Woodson, Assistant Secretary of Defense for Health Affairs. 

The panel discussion comprised Dr. Kevin M. De Cock of CDC, Dr. H. Clifford Lane of NIH, Dr. Regina Rabinovich of the Bill & Melinda Gates Foundation, Dr. Daniel Gordon of Sanofi Pasteur, and Ambassador Michael Ranneberger, former U.S. ambassador to Kenya. 

 

     Above: A Highlight Video from the event.

Video of the full report launch is available here.

Speakers highlighted the DOD laboratories’ contributions to medical research for both the United States and their partner countries, including scientific breakthroughs on infectious diseases such as malaria.  The data they collect is beneficial for medical research not only for the host nation but also for health globally. Another great asset, panelists said, is the laboratories’ set of dynamic partnerships, spanning the DOD, other government agencies, industry, academia, other research institutions, and local schools and clinics throughout the region.

Ultimately, argued the panelists, the DOD laboratories are a win-win for United States national interests and global health. They strengthen U.S. military readiness while simultaneously building medical and research capacity in their host countries. 

At the same time, panelists observed that the DOD overseas medical research laboratories face inherent vulnerabilities and challenges due to unawareness of their work among top policymakers, a shortage in sustainable and predictable core funding, and the difficulties of adapting Army and Navy personnel guidelines to a medical research mission. 

Assistant Secretary Woodson told the laboratories to make their case more strongly and better advertise the good work they do. He said that the laboratories play an important role in building healthy populations globally, a strategic approach to promoting economic and political stability worldwide. 

Related Content

GAVI Going Forward

Written by Matthew Pesesky

On June 13, 2011 the GAVI Alliance, the international public-private coalition focused on expanding access to new and underused vaccines in low-resource settings, held its first-ever pledging conference in London to secure financial commitments from new and existing donors. GAVI’s fundraising target was $3.7 billion, yet the alliance received commitments totaling $4.3 billion from national governments, corporations, individual donors, and NGOs. The conference succeeded in securing financial support to fund the record number of requests received by GAVI, but significant challenges remain as GAVI continues to expand its coverage. The “GAVI Going Forward” event, hosted jointly on June 27 by CSIS and the Center for Global Development (CGD), looked at how GAVI can mitigate its weaknesses and leverage its strengths to save and improve the lives of the world’s most vulnerable children.

Lisa Carty of CSIS and Amanda Glassman of CGD moderated a panel discussion featuring Amie Batson, USAID Deputy Assistant Administrator for Global Health; Joelle Tanguy, Managing Director of External Relations for GAVI; Nicole Bates, Senior Program Officer for the Bill & Melinda Gates Foundation; and Claire Moran, Development Counselor at the British Embassy.

Joelle Tanguy described the vision and political will that made the GAVI pledging conference a success. Tanguy spoke of the importance of continuing to work with recipient countries to increase co-financing and contributions from first-world and emerging market donors.  The challenge going forward, Tanguy noted, will be to quickly demonstrate that GAVI is a “best buy” by measuring and documenting expanded coverage and increased equity accomplished through GAVI initiatives.

 

Amie Batson said that GAVI’s superior track record justified additional spending despite large-scale fiscal challenges. GAVI’s extensive and unified bargaining power, Batson said, allows it to lower the price of vaccines and create markets for vaccines which might not otherwise be produced on a large scale. This influence on market shaping allows the U.S. to leverage its contributions approximately eight-fold. Investments in GAVI, she said, are not entirely altruistic, as increased vaccination abroad effectively prevents the spread of infectious diseases to the U.S. and other donor countries.

Claire Moran spoke to the motivation behind the UK’s $1.3 billion GAVI pledge. GAVI offers “value for money, transparency and results,” Moran said, as supported by GAVI’s high marks in the UK’s recent review of its foreign aid programs. Because of these assets, GAVI is a unique institution, difficult to replicate in other sectors. As a truly global alliance, Moran emphasized, GAVI was able to provide mutual benefit for its partners and mobilize the kind of unity that led to the pledging conference’s success.

Nicole Bates highlighted how vaccines improve economies and political stability, serving both national and international interests. A challenge for future GAVI funding is to broaden the donor base to incorporate more allies from around the globe and to turn recipient countries into donor countries. Finally, Bates said that insufficient funding is no longer an excuse for the 15 to 20 year gap between childhood vaccine access in developed and developing countries. GAVI’s difficult task is to overcome the other factors that impede access in developing nations, to ensure global vaccine equality.

The “GAVI Going Forward” event offered perspectives on the dramatic show of support for GAVI on June 13th. With increased funding in hand, pressure will be on GAVI to show measurable increases in vaccine access. To continue to make the dramatic impact that the alliance achieved in its first decade, GAVI will need to better tell its story, diversify and expand its donor pool, and work to increase levels of ownership and investment among recipient countries.

Related Content

Report: The Defense Department’s Enduring Contributions to Global Health

In the spring of 2010, CSIS launched a year-long, independent examination of the U.S. Army and Navy overseas medical research laboratories. The impetus was an awareness that despite the laboratories’ impressive scientific accomplishments and contributions to U.S. national interests and global health, they are not well understood outside of research circles and consequently find themselves undervalued in today’s environment of fiscal austerity. They stand at the intersection of health and security, a topic of increased importance to U.S. approaches to global health.

The CSIS project aimed to assess the laboratories’ contributions and achievements; examine the factors that constrain their performance; and propose reforms that will put them on the best course to continued success. It included considerable background research, three formal meetings of experts, travel to five overseas laboratories, and interviews with dozens of laboratory researchers and collaborators. This report lays out the project’s research, conclusions, and recommendations.

Download the report.

Please use the comment form below to provide feedback!

Related Content

China’s Emerging Global Health and Foreign Aid Engagement

Xiaoqing Lu Boynton
Fellow, Freeman Chair in China Studies, CSIS

On May 24, CSIS co-hosted with the China Institute of International Studies (CIIS) a conference on China’s emerging global health and foreign aid engagement. The conference was held at the CIIS office in Beijing. Commissioned experts from China and the United States presented their preliminary findings on various aspects of the two countries’ presence in Africa, including advantages and effects of U.S. and Chinese efforts in Africa, U.S. and Chinese responsibilities in promoting global health programs, and the Chinese government’s domestic decision-making process on aid in Africa, among other topics. The discussion focused primarily on developing a practical roadmap on U.S.-China-Africa trilateral collaboration.

Participants agreed that global health was one of the most promising areas for U.S.-China-Africa trilateral collaboration. Nevertheless, significant challenges exist. These include the lack of appropriate funding for trilateral ventures, human resources for trilateral initiatives, and a concrete and detailed action plan. Several key issues were identified as areas for potential global health collaboration – neglected tropical diseases, improving nutrition, and pandemic preparedness in Africa. Conference participants also offered constructive suggestions for future collaborative efforts, including the establishment of an oversight and review mechanism as well as metrics for success.

As a next step, the CSIS Freeman Chair in China Studies and Global Health Policy Center will publish the six commissioned papers in the summer of 2011, with policy recommendations for Beijing and Washington on a roadmap for future collaboration. The report will be disseminated in policy communities in the United States and China. This project is part of a larger CSIS initiative analyzing how emerging economies are engaging on global health issues through diplomatic and bilateral assistance channels. CSIS plans to convene a conference in the fall with policy and opinion leaders from various partner organizations in the BRICS countries to build on current research and articulate recommendations for enhanced cooperation and coordination in the global health arena.

Related Content

Report: Leveraging the World Health Organization’s Core Strenghts

The World Health Organization (WHO) was formed in 1948 to act globally as the “directing and coordinating authority on public health” to promote the “attainment by all peoples of the highest possible level of health.” Under this broad mandate, WHO has contributed to historic public health advancements, such as the eradication of smallpox, achieved in 1979, and galvanizing its members around the Framework Convention on Tobacco Control, which entered into force in February 2005. At present, there is a U.S. government interagency review under way on policy approaches to WHO, along with calls from independent critics to reform the body’s governing charter. On the question of whether WHO has value to U.S. global health policy and U.S. national interests, the answer, in the opinion of the authors of this paper, is decidedly yes—provided that WHO narrows its focus strategically to those activities for which it is best suited and for which it has the greatest prospects of delivering substantial value.

Download the report.

Please use the comment form below to provide feedback!

Related Content

The Exclusive Business of Disaster Relief

Ronald Waldman
Global Health Fellow, USAID and Professor of Clinical Population and Family Health, Columbia University

Following the Haiti earthquake of January 12, 2009, a variety of factors contributed to the atmosphere of ultimate chaos that reigned for the first few months of the relief effort.  First and foremost were the circumstances of the disaster themselves – a major seismic event occurred in close proximity to the shoddily constructed capital city of the country, resulting in 230,000 deaths, hundreds of thousands of injuries, the literal (not to mention the functional) collapse of the government, and the abrupt end of whatever semblance of ‘normal’ life had previously existed.  Major population movements both away from and towards the shattered city were impossible to track.  Whatever health care facilities remained standing were absurdly and obscenely overcrowded, under-staffed, and inadequately supplied. 

Despite all this, two things worked remarkably well.  First, food distribution.  A combination of agencies including the World Food Programme, USAID’s Office for Foreign Disaster Assistance, and US Department of Defense forces working together with Menustah (the UN military contingent that had been on-site prior to the earthquake) devised a workable system of vouchers and established a network of distribution sites that were secured and made functional in record time.  Food availability, the lack of which could have provoked major outbreaks of civil unrest, never became a problem.  Second, a breakdown in public health never occurred.  For reasons which are not completely understood, but which probably have a lot to do with good luck, the world did not witness the “disaster after the disaster” – a public health collapse caused by large numbers of people living in crowded conditions with inadequate shelter and essentially no sanitation facilities.  No important epidemics of diarrhea, respiratory illnesses, vector-borne diseases such as malaria and/or dengue, or other important communicable diseases were detected.  On the public health front, things remained relatively calm and under control from January until October, when the much-publicized and discussed cholera outbreak occurred.  Although more could have been done to restore both public and private sector activity, including more rapid removal of rubble from the earthquake area, more rapid resettlement of the large displaced population, and more rapid rehabilitation of the health system and other vital societal functions,  this six month relative lull in action allowed relief efforts to concentrate on providing intermediate-term care for physical rehabilitation, some repair of damaged facilities, and the matching of available resources (human, material, financial) to the new needs of clinics and hospitals.

Two things from the negative side of the ledger are also worth mentioning.  The descent upon Haiti of hundreds of groups and thousands of people coming to ostensibly provide assistance to the beleaguered population had the undesirable effect of contributing to the chaos.  While many of those who arrived were motivated by a laudable generosity of spirit, a selfless desire to help the unfortunate, and even, in many instances, a desire to put appropriate skills to good use, the inexperience of many of these newly-created “NGOs” slowed the ability of experts in international disaster relief to get organized, to rationally order priorities, and to provide appropriate supplies to the places that needed them most.  Haiti – a country whose health services were already dominated by the presence of NGOs, both large and small, both competent and other – was newly deluged with groups from around the world.  It is not clear why, in situations where one of the most important commodities is the good judgment that comes from long and hard-earned experience, the early days of large relief scenes tend to be dominated by the presence of  young, idealistic, disaster ‘rookies’.   If these people were working under the aegis of experienced organizations they could make a major contribution in both the present and the future; many, however, come either unattached or under the banner of NGOs that have formed overnight, that are under-resourced and under-equipped, and that have not taken the time to carefully consider whether or not they can actually make a useful contribution.  Over 350 organizations were registered in the official “health cluster” – the coordinating mechanism of the UN relief operation – far too many to allow for the dissemination of any but the most superficial information.  There are times, I find, when the most appropriate answer to the frequently posed question “we just got here last night – where can we go to help?” is blunt: “home”.  Emergency relief, especially in the health sector, needs to become a more exclusive business, more the domain of experts than of volunteers. When so many lives depend on an efficiently operating system and when skilled personnel with adequate support are at a premium, some sort of licensing or certification should be required by the authorities.  But no such system is in place and emergency relief remains, to an excessive degree, a   business where amateurs are made welcome.

The other problem that arose in Haiti is more nuanced and has to do with the nature of the injuries that resulted from the earthquake and the level of care that was provided.  In addition to the inexperienced providers mentioned above, highly-skilled teams of crack emergency medical professionals quickly arrived on the scene.  These included a slew of orthopedic and neurological surgeons who worked under the auspices of the US Department of Health and Human Services, the US Department of Defense, the public and private sectors of many other countries from around the world, a variety of major academic institutions and all of the most professional and experienced NGOs .  The medical teams worked heroically, treating patients for injuries that could not have been treated successfully in pre-quake Haiti, given its state of poverty and under-development.  But that was the problem.  The new level of care that became available within weeks was far higher than what could be maintained.  Patients who had suffered serious spinal cord injuries and severe head trauma who might not have survived were it not for the surge of external support, now required long-term rehabilitation and support that was simply not available.  Hardly any of the organizations that provided the life-saving interventions were in a position to provide the long-term follow-up that became necessary.  In other words, the rush to save lives in the immediate was undertaken (heroically) with insufficient regard for the longer-term consequences.  Unfortunately no studies exist that document these consequences.  Triage is one of the basic principles of emergency medicine, especially in situations of mass casualties, but based on what I saw, I do not feel it was it was applied well in Haiti.  The power to decide who should live and who should die is something no one wants, but is, nevertheless, a function that had to be exercised in the horrible circumstances of post-quake Haiti.   Guidelines for the provision of an appropriate level of care should be put in place prior to the next major disaster.

Some things went right with the health sector response to the Haiti earthquake, and some did not.  The magnitude of the catastrophe brought out the need to fix lingering problems with the existing humanitarian assistance architecture.  In emergency response, many of the decisions that need to be made will be difficult and not politically popular, but the focus needs to be unwaveringly and unflinchingly on providing those in need with the best possible care, not with giving those who are willing to provide that care the best opportunities to do so.

Ronald Waldman was coordinator of the United States government health sector response to the Haiti earthquake.

Related Content

Despite Progress, More Work is Needed to Control Infectious Diseases in Nigeria

Phillip Nieburg
Senior Associate, Global Health Policy Center, CSIS

A recent visit to an HIV/AIDS conference in Nigeria gave me an opportunity to discuss with colleagues and to review recent reports on several important infectious diseases in that very large and diverse country. The progress report was decidedly mixed.

On the bright side, Nigeria, a country with a population greater than 140 million, appears to have made excellent progress in regaining control over paralytic polio. It had previously been the only African country that had not eliminated polio from within its borders, and as a consequence over the last several years, polio viruses spread from Nigeria to several other countries, some of which have not yet brought their polio outbreaks under control. However, the most recent data from Nigeria indicating few recent polio cases means that Nigeria has not only brought its own outbreak under control but also, there is now a lower risk of the spread of polio from Nigeria.

On the other hand, Nigeria is now experiencing a large outbreak of cholera, a severe and sometimes fatal bacterial infection that spreads person-to-person through contaminated water and food, most often in areas where adequate sanitation is lacking. As of October 26th, reports indicated that more than 40,000 Nigerians have been sickened and more than 1,500 have already died of the disease. Although cholera cases are usually reported in Nigeria during its rainy season, the magnitude of this year’s outbreak is unprecedented, said to be the largest in 20 years. The reason for this outbreak appears to be flooding from the unusually heavy rains that have fallen in this year’s rainy season. Authorities are hopeful that the oncoming dry season will help their ongoing disease control efforts.

Malaria remains another problematic disease burden for Nigeria. Data from the World Health Organization and from the global Roll Back Malaria Program indicate that in 2008, the most recent year with global data available, Nigerians experienced nearly one of every six malaria infections in the world. Because malaria is a major cause of infant and young child mortality, it seems clear that better malaria control is a pre-requisite for further reducing the country’s infant mortality and child mortality rates. Equally concerning is a recent report that reveals a large proportion of blood donors in Nigeria are infected with malaria and that Nigeria’s current malaria screening practices may not be adequate to prevent malaria transmission through blood transfusions.

Nigeria’s HIV/AIDS Conference
Nigeria has an estimated 3 million HIV-infected people, more than half of whom are women. The HIV/AIDS conference I attended, co-sponsored by Nigeria’s National Agency for the Control of AIDS, focused largely on options for increasing HIV testing and counseling (HTC) rates in that country. HTC represents both a gateway to AIDS treatment for those found to be infected and a gateway to more focused HIV prevention efforts for those found to be uninfected. Yet only 6-14% of Nigerians over 15 years old have been tested and counseled for HIV, meaning that more than four out of every five HIV-infected Nigerians are unaware that they are infected.

Preliminary results were presented from HIV prevention awareness surveys carried out by the Research Alliance to Control HIV/AIDS (REACH), a multi-year collaboration between Northwestern University (Evanston, IL) and Nigeria’s University of Ibadan. Data from these community studies confirmed the low HTC uptake and identified associated factors such as lower income levels and lower levels of completed schooling. Other factors linked to low HTC uptake included lack of awareness of nearby HTC sites, fear of stigma and fear of having to disclose results to family members and/or sexual partners. The youngest survey respondents, i.e., those 15-17 years old, had HTC rates much lower than older respondents, possibly because they were at lower actual risk of being HIV-infected. Another possible reason for this, though, could be that Nigerian law – requiring parental consent for medical procedures for those under 18 years – had been an obstacle to their seeking HTC.

Among the options for moving forward discussed at the conference were an explicit focus on testing and counseling of couples (a technique already in use in several other African countries), use of mobile testing teams that would allow HTC to be done outside of formal health facilities, and a greater use of “opt out” HTC, in which people coming to hospitals and clinics for almost any reason are routinely told about the program and tested and counseled for HIV unless they ask not to be included. REACH survey respondents had been very positive (>80% acceptance rate) about accepting each of these options.

The conference also marked the beginning of a transition for REACH from a formal collaboration between Northwestern and the University of Ibadan to a project totally under the control of Nigerian institutions. Although Nigeria still has a long way to go to get HIV/AIDS under optimal control, I was impressed by the determination expressed at the conference by Nigerians in both government and academia; these leaders are committed to addressing outstanding HIV/AIDS challenges by using available data to make necessary policy changes.

Related Content

Where Does the Money Go?

Julia Nagel
Web and Social Media Assistant, Global Health Policy Center

On October 15th, the United States Institute of Peace held an informative event entitled – “Relief Efforts in the Wake of the Pakistan Floods.” Among the panelists were Mark Ward of USAID/OFDA, Rabih Torbay of the International Medical Corps, and Moeed Yusuf of the U.S. Institute of Peace. All of the panelists held an expert knowledge of Pakistan and each had been to Pakistan since the flooding began.

US Relief EffortsThough many themes arose throughout the event, I felt that each topic discussed, each challenge presented, and each lesson extrapolated all revolved around one central question: where does the money go? In fact, Mark Ward mentioned that in the countless interviews he’s participated in, he is asked this question in almost every single one.

Although answering this is no easy feat, I think the persistence and stubbornness of this question reveals a tremendous amount about how foreign aid is perceived. The Pakistan floods have affected over twenty million people; this far exceeds the combined total of those affected by the 2004 Indian Ocean tsunami, the 2005 Kashmir earthquake, and the 2010 Haiti earthquake. Yet charitable donations for Pakistan’s flood have been slow to arrive and beyond this, a considerable majority of foreign aid has come from the United States. While there are numerous theories as to why this is – donor fatigue, tightened budgets during a recession, mistrust of the Pakistani government and how it would spend aid – I also think, all too often, people do not actually know where the money goes. A poll conducted by the Kaiser Family Foundation in September, for example, concluded that Americans are skeptical of foreign aid but look favorably on money spent towards public health initiatives abroad. This is a clear example of how perceptions of aid do not align with reality.

So where does the money go? All three panelists agreed that in addressing this natural disaster, the first priority has been to avoid a public health catastrophe. The floods submerged one third of Pakistan, a country roughly the size of Florida. The vulnerability to disease outbreak was acute. However by acting swiftly – the U.S. military, NGOs and Pakistani health officials were able to deliver basic services to millions of people and prevent countless epidemics. As of September 30th, the international community contributed over $620 million towards Pakistan’s relief effort; over $200 million of this was put towards food security, $50 million towards health initiatives, $25 million towards nutrition, and $57 million towards water, sanitation, and hygiene. In essence, about half of foreign aid went towards ensuring that the floods did not produce another disaster: infectious disease epidemics.

Rabih Torbay stressed that in emergency situations like these, early money is what saves lives. His organization, The International Medical Corps, has been in Pakistan since 1984 training Pakistanis in public health and development. Because of this continuing relationship and deep investment in the country, Torbay said, trained Pakistanis were the first line of response to the floods and certainly, one of the most effective.

It seems from these examples that often times, when money is spent effectively, people do not see where it goes. This is because it prevents public health emergencies; it wards off starvation; and it trains officials on the ground. While millions of Pakistanis are still displaced from the floods, health problems are still prevalent, and there are numerous examples of foreign dollars not being appropriately spent, there is no question that aid was effective in saving lives and forestalling a public health catastrophe. The problem is, as Mark Ward expressed, the international community simply could not meet the need for an event of this magnitude. Thus we need to change our methods of operation – especially in Pakistan. We need to foster long-term relationships and continue developing these relationships after the cameras stop rolling. If we do not do this, we will have to start from scratch if/when the next disaster occurs and we will lose any trust the Pakistani people have in the international community.

Trust is enormously important. All three panelists agreed that while the Pakistani floods are tragic, this is a key moment for the United States to improve its image in Pakistan. All aid, therefore, must be marked with an American handshake or some sort of signage, to prove it is being provided by the U.S. Though this idea seems simple in theory, both Ward and Torbay mentioned that NGOs are often put at risk when the Taliban knows the food they are providing or the medicine they are administering is supplied by America. It doesn’t benefit the U.S. or any other donor government if NGOs cannot operate and carry out their relief efforts.

Both Torbay and Yusuf shared the view that the U.S. needs to put more pressure on the Pakistani government to publicly acknowledge that the majority of assistance is funded by U.S. dollars. Yusuf added that the U.S. must do a better job of publicizing its role in the flood relief. Yusuf’s point was made all the more clear when, during the Q & A portion of this October 15th event, a reporter from Voice of America asked Mark Ward: in Sindh province, where does the money go? Though somewhat comical – because Mark Ward opened the event mentioning that he cannot avoid this question – it is incredibly telling that after an hour discussion about American relief efforts, this question still surfaced.

Mark Ward answered the reporter with various statistics and then added that perhaps, in dangerous parts of Pakistan, the U.S. doesn’t do a great job telling its story. I would argue that the U.S. needs a new strategy on how to do this and it needs to do so quickly. If the U.S. doesn’t clearly define its intentions and answer the recurring question – where does the money go? – someone else will. 

Related Content

Important Improvements Towards Water Sanitation

Katherine Bliss
Deputy Director and Senior Fellow, Global Health Policy Center and Senior Fellow, Americas Program

Last week I wrote about the persistent challenge of sanitation, noting that the world is not on track to reduce by half the proportion of the population without sustainable access to sanitation, one of the targets of MDG 7 focused on ensuring environmental sustainability. At least 2.6 billion people worldwide lack access to basic facilities. Even if current efforts to put in new systems remain constant, that number is projected to rise, thanks to population growth and the need to maintain existing infrastructure.

Beyond its deleterious effects on the environment, the lack of sanitation has negative implications for health. Diarrheal diseases are the second leading cause of childhood mortality in the developing world; nearly two million people, 90% of whom are children, die from diarrhea each year. But safe disposal of feces is estimated to reduce diarrheal disease by up to 40% in some areas, while drinking water interventions alone have been shown to reduce diarrhea by 25%. And the economic benefits of sanitation are impressive. The Geneva-based World Water Supply and Sanitation Collaborative Council (WSSCC) reports that every dollar spent on sanitation in developing countries leads to a nine dollar economic return over time.

Both at the September MDG Summit -- and since then -- there have been positive signs that the international community intends to accelerate efforts to improve access to sanitation over the next five years. Sanitation activities were mentioned several times in the Summit’s outcomes document, and high-level side events raised high-level awareness of the challenges that remain.

Last month the Sanitation and Water For All process formalized its partnership and steering committee “to increase political prioritization, promote evidence-based decision-making and support strong national processes” in bolstering cooperation and support for sanitation projects. Members include a range of developing and donor countries, multilateral organizations and development banks, civil society organizations and professional associations that have agreed to work together to raise awareness and support the implementation of sanitation activities at the household and community levels.

The WSSCC is also making progress with its Global Sanitation Fund. Launched in 2008, the Fund pools money from donor countries and organizations and makes it available to countries that meet its application criteria, allowing governments and sub-grantees to carry out sanitation projects. Earlier this year the Fund announced its first program, a $5 million investment in Madagascar. Six other countries, Burkina Faso, India, Nepal, Pakistan, Senegal and Uganda, have received support in the first round, and a second round to focus on Bangladesh, Benin, Cambodia, Ethiopia, Kenya, Malawi, Mali, Nigeria, Tanzania and Togo is underway.

More recently, a group of water and sanitation advocacy groups and implementing organizations launched the “Raising Clean Hands” initiative to highlight the importance of including schools in water, sanitation and hygiene programs. Ensuring sanitation facilities are in place in schools not only protects children’s health and educational experience but also encourages students to advocate for water, sanitation, and hygiene programs within their communities. At the same time, evidence suggests that in some regions parents are reluctant to send girls to school if they cannot count on private latrine or toilet facilities, so providing sanitation in schools is a way of encouraging girls’ education, specifically, and gender equality, more generally.

All of these examples underscore the importance of developing and strengthening cross-sectoral sanitation partnerships involving governments, universities, NGOs, the private sector, and communities. It is especially important that governments and communities, themselves, prioritize sanitation interventions if there is to be progress on the MDG sanitation target. With scarce resources and competing priorities, putting sanitation at the top of the list can be a challenge. But with children’s health, environmental conservation, education quality, economic savings, and gender equity at stake, there is no time to waste.

Related Content

Can an Equity Focus Accelerate Progress in Child and Maternal Mortality in the Next Five Years?

J. Stephen Morrison
Director, Global Health Policy Center

One intriguing proposition for doing business differently over the next five years, vis-à-vis achieving the Millennium Development Goals (MDGs) by 2015, has come from UNICEF and its new executive director Anthony Lake.

reportBased on a four month study, ‘Narrowing the Gaps to Meet the Goals,’ released in early September, UNICEF proposes that major gains in child (MDG-4) and maternal (MDG-5) health can be achieved through an “equity focus” – concentrating in a new and disciplined way on the lowest quintile (20%) of women and children living principally in low income, high mortality countries. This is a refreshing new idea. 

The report argues that since 1990 disparities in poverty and child development persist or have worsened, despite a significant reduction in under-five mortality in low income countries. These improved averages conceal persistent, nagging gaps that should now be the priority focus of UNICEF and others’ efforts.

UNICEF acknowledges that reaching these populations can be costly and difficult: owing to remoteness, poor transport access, and weak infrastructure. Nonetheless, it argues that an equity focus can accelerate progress in MDG 4 and 5, reduce disparities, be cost effective, and reduce the out-of-pocket expenditure for the poor if a strategy concentrates on three steps: (i) upgrade select facilities for maternal and newborn care, including “waiting homes” for pregnant women; (ii) expand outreach services, eliminate user charges, extend cash transfers to the poorest to cover transport and other costs that impede use of services; and (iii) task shift – place greater reliance upon community-based health workers.  UNICEF's report adds that preventive, promotive and curative principles need to underpin these steps:

“Preventive measures seek to prevent disease and undernutrition and to support pregnant women. Examples include immunization, micronutrient supplementation, antenatal care and prevent of mother-to-child transmission of HIV. Promotion measures foster feeding, hygiene and sanitation practices… early and exclusive breastfeeding, hand washing with soap, correct and comprehensive knowledge of HIV, and the use of insecticide-treated nets to prevent malaria are four such interventions… Curative measures aim to treat disease and conditions, and to support mothers and newborns during delivery and in the postpartum period. They include… antibiotic treatment for pneumonia, skilled attendance at delivery and emergency obstetric care, treatment of severe acute malnutrition, and prophylaxis and pediatric treatment for HIV and AIDS.”

UNICEF’s bold proposition attempts to speak to the moment we are in - of the need to renew the value proposition that equity lies at the core of global health; of making strategic use of responding to the considerable recent accumulated experience of what interventions work best; and of responding to increasing budgetary pressures and the need to demonstrate efficiency and prove concrete impacts through select, core steps, better data and better measurement.

For now, the UNICEF proposition rests on a modeling exercise; full proof that it can be successful lies ahead. It will be important for this approach to be put into practice in countries, with clear strategies, time lines, and budgets: how much will it cost to bring this vision to scale.  And how quickly will we know whether the strategy is succeeding?  It will also be important to clarify better what these changes will mean in terms of UNICEF and others stopping certain other activities. Finally, it will be important to explain how an equity focus can be reconciled with a U.S. approach which, according to President Obama's speech to the MDG Summit at the United Nations in September, will make development and health investments in countries that are governed well: that show economic growth, progress in anti-corruption, greater accountability and commitments and investing in their own budgets personnel and services.  The UNICEF singular focus on equity is thus far quiet on how important governance will be in making future investments. 

 

**Anthony Lake was at CSIS on Wednesday October 20 and presented this proposition to a gathering of experts. Please watch the event below**

 

Related Content

A Cause for Optimism After the MDG Summit

Katherine Bliss
Deputy Director and Senior Fellow, Global Health Policy Center and Senior Fellow, Americas Program

From the backseat of a taxi stalled in mid-town Manhattan, idling as motorcade after motorcade carrying high-level officials sped by, it might have been difficult to believe that developing world environmental health challenges would get much play at last month’s MDG Summit. However, the high-profile focus on the need to reinforce global efforts on sanitation and the launch of the Global Alliance for Clean Cookstoves offered a cause for optimism, even as the challenges loom large.

Heading into the summit, there was good news that the world is on track to meet the target of reducing by half the proportion of people without sustainable access to safe drinking water by 2015 compared to the baseline year of 1990, contained in Goal 7 to Ensure Environmental Sustainability. Within 5 years the United Nations estimates that 86% of the population in developing regions will have access to an improved source of drinking water. That’s up from 71% in 1990, a fairly impressive achievement when one takes population growth into account, even if significant urban-rural disparities remain.

'But progress on the effort to reduce by half the proportion of people without access to basic sanitation by 2015 is a different story. Right now 2.6 billion people lack access to improved sanitation, such as a toilet or a latrine. The UN warns that even at present levels of effort, that number could be even higher by 2015, making it unlikely the world will reach the sanitation target without new energy and fresh resolve.

To raise delegates’ awareness of global sanitation challenges, the Republic of Korea, Liberia, Senegal, Tajikistan, and the United States convened a high-level side event on September 22. The goals were to focus on the Sanitation and Water for All Global Framework for Action and to underscore the importance of reaching the water and sanitation targets as a means of fulfilling the broader range of health and gender-related MDGs. Speaking at the meeting, the Crown Prince Willem-Alexander of the Netherlands, who heads the UN Secretary-General’s Advisory Board on Water and Sanitation, emphasized the importance of researching and scaling up interventions to reach the poorest of the world’s poor.

Sanitation issues were featured in the UN Summit’s outcomes document, as well. In the text, world leaders committed to “redoubling efforts to close the sanitation gap through scaled-up, ground-level action, supported by strong political will and increased community participation, in accordance with national development strategies....” Recognizing that providing basic sanitation was one topic on which there had been “slow progress,” the text outlines a global effort to realize “Sustainable sanitation: the five-year drive to 2015.”

The launch of the Global Alliance for Clean Cookstoves on September 23 focused on the challenge of reducing the exposure of family members to indoor air pollution created by burning wood and other biomass for heating and cooking in the home. At least 3 billion people worldwide lack access to improved energy sources and rely on traditional cookstoves or open fires for preparing their food each day. The World Health Organization (WHO) identifies indoor air pollution as the fourth greatest health risk in the developing world and estimates that nearly 2 million people die each year as a result of exposure to harmful smoke and toxins. Women and small children, who spend the most time inside tending to domestic duties, bear the brunt of such exposure, suffering from burns and respiratory infections as well as chronic obstructive pulmonary disease (COPD).

Beyond the health and gender challenges associated with indoor air pollution, the collection and burning of wood for fuel contributes to deforestation and climate change, as well.

To contribute to efforts to “save lives, improve livelihoods, empower women, and combat climate change,” the Alliance, a public-private partnership, aims to ensure 100 million households adopt clean stoves by 2020 by promoting a market for clean cookstoves, and mobilizing the resources of government, international organization, NGO and private sector partners to raise awareness and identify solutions in diverse contexts. Founding partners include the United Nations Foundation and the Shell Foundation, along with agencies within the governments of Germany, the Netherlands, Norway, Peru, and the United States, and within the UN system, including WHO, the World Food Program, UNEP, UNIDO, and the UN High Commissioner for Refugees.

At the September launch, high-level speakers emphasized the importance of coordinated and inter-sectoral efforts to address the multiple challenges linked to traditional fuel use patterns. Head of the UN Foundation Tim Wirth moderated the session, which featured remarks by Peru’s First Lady Pilar Nores de García; Former Prime Minister of Norway and Chair of the World Commission on Environment and Development, Gro Brundtland; María Neira, head of WHO’s Environmental Health section; and Melanne Verveer, U.S. Ambassador at Large for Global Women’s Issues.

While the Alliance continues to recruit partners, and its plan of action remains to be developed, the launch in New York was a good step in raising public awareness about the importance of improving access to improved household energy sources and in catalyzing action to address a problem that, like lack of access to basic sanitation, significantly affects the health and well-being of the world’s most vulnerable sectors.

 Related Content

Peru’s Human Plague Outbreak: Rats, Sugarcane, and the Challenges of Regional Education and Response

Michèle Ledgerwood
Senior Research Fellow, Global Health Policy Center, CSIS

During a visit to Peru in late August to research the scientific contributions and regional partnerships of the U.S. Naval Medical Research Center Detachment in Lima and its permanent field office in Iquitos, our CSIS team had recurrent conversations about the recent outbreak of human plague in the district of Chocope, department of La Libertad, roughly 600 kilometers (375 miles) north of Lima.

labPeru is no stranger to infectious diseases, acute febrile illnesses, and recurrent viral infections, many of which are zoonotic or vector-borne in origin. Yellow fever, dengue fever, and various strains of influenza are annual visitors, and 2010 has seen outbreaks of both Oropouche fever and human rabies as well (the latter transmitted by vampire bats). The diversity of Peru's geographic landscapes – from desert to mountain highlands to lush jungle – results in a rare variety of both disease and immunological response. In the coming years, the completion of the Interoceanic Highway has the potential to broaden the complexity of the epidemiological environment even further.

During this summer's outbreak, 31 cases of human plague were reported in the space of two months, resulting in three deaths. The majority of those cases were bubonic, with four pneumonic and one septicemic. Although isolated cases of human plague are reported in Peru almost every year, this was the country's first epidemic of bubonic plague since 1994, when 35 people died and more than 1,100 infections were diagnosed.

The recent outbreak was of particular concern to Peruvian public health officials and researchers because it occurred in a province that is home to two of Peru's most important export harbors and is traversed by the Pan-American Highway. Bubonic plague generally is carried by rodents and transmitted to humans either by fleas, who act as vectors for the disease, or via human handling of infected animals (alive or dead). In Chocope, rats reside in the sugarcane crops. When the crops are burned prior to harvest, the rats flee to the surrounding farming huts, triggering the onset of human infection.

One official we interviewed suggested that the Peruvian Ministry of Health's (MOH) initial concern stemmed from reports of an apparent lack of mortality in the infected rats, and a fear that they might migrate en masse to nearby urban areas. This possibility is still being researched. If true, it could have interesting implications for future outbreaks, particularly as global warming trends portend an increase in the number of host rodents in the years to come.

As neighboring Bolivia contends with its own outbreak of bubonic plague, Peru continues its surveillance of the disease, and the MOH is working on a broader public education campaign. Although Peru's economy continues to grow and the country is beginning to roll out a girlslong-anticipated framework law for Universal Health Insurance (Aseguramiento Universal en Salud), significant inequalities remain. The extreme poverty and abysmal hygienic conditions in many Peruvian villages create the potential for more rapid and extensive transmission of disease during an outbreak. Improving the dissemination of health information in both rural and remote areas therefore is critical.

The implementation of Peru's national health policies is the responsibility of each individual Regional Health Authority (Dirección Regional de Salud, or DIRESA) in Peru's 25 regions. Not surprisingly, there are significant geographic disparities in both the quality of healthcare services and the management of outbreaks. As a result, the Pan American Health Organization (PAHO) is advocating for better education of both regional health providers and regional governments. One of the recent victims of fatal pneumonic plague transmission was a medical student at the Universidad Nacional de Trujillo, who intubated an infected patient without taking adequate prophylactic measures. A recent statement by fellow medical students in support of their deceased colleague directly targets the incident management approaches of the La Libertad DIRESA, and highlights the challenges of implementing appropriate epidemiological practices across disparate regions – an issue that PAHO sees as critical.

For an excellent Spanish-language article on public health concerns related to the plague outbreak in Peru, please see PAHO's website here. For more general information on the plague, please see the U.S. Centers for Disease Control and Prevention's Plague Home Page.

What are your thoughts about Peru’s plague outbreak? What public health education strategies would be most effective in this context?  Leave your comments below.

Related Content

A Phone Call from USAID

phoneLast Friday, September 17th, USAID held a phone call with various news and policy institutions providing a preview of USAID’s agenda going into the United Nations General Assembly.

The first voice on the phone was Dr. Rajiv Shah, Administrator of USAID. Dr. Shah expressed that the Obama Administration fully embraces the Millennium Development Goals (MDGs) and beyond this, thinks that all 8 goals are attainable by 2015. This upcoming conference (starting September 20th) is about bringing nations together and celebrating the achievements that have been made since the Millennium Development Goals were first delineated. Because indeed, achievements have been made. However the Summit is also crucially about highlighting areas where we can do better. One amongst these is improving maternal health, MDG5. At the end of the day, Dr. Shah concluded, the summit is a call to action. If the MDGs are going to be achieved by 2015, than this summit must invigorate the international community to do more.

Leonardo Martinez-Diaz, Senior Advisor to USAID, then took over the conversation outlining three points USAID hopes to convey at the UNGA. First, he said, the MDGs are about development. We need to move far away from the notion that the MDGs are humanitarian relief or simply money towards a temporary solution. Such ideas get us nowhere. To the contrary, the MDGs are about a development process and long-term sustainability for all countries involved.

The second point he made expounded upon earlier remarks from Dr. Shah: if the MDGs are going to be reached by 2015, historic leaps need to be made in the present. The words Mr. Martinez-Diaz continually used when talking about this were “force multipliers.” We need to begin combining ideas that work to ensure the greatest success in a short period of time. One of the most obvious examples of “force multipliers” is women and girls. When the international community invests in women and girls, we concurrently invest in all of the Millennium Development Goals; enabling and educating this untapped group is proven to alleviate poverty, enhance security, and improve a host of other issues (Melanne Verveer echoed these points when she spoke at CSIS.)

Beyond this, he added, we need real innovation. Mr. Martinez-Diaz stressed that innovation can mean many things. For example, innovation can mean providing new solutions such as technology, drugs, or transportation to development challenges. However innovation can also mean taking existing solutions – that are proven to work – and delivering them to greater numbers.

Last, Mr. Martinez-Diaz stressed the importance of partnerships. How do we, as agencies and organizations, work better together? How do we go beyond the rhetoric of collaborating to actually allowing that to occur? This will be an important theme going into the UNGA and certainly one that requires a dialogue throughout the summit.

Let us know what you think about USAID’s ideas heading into the United Nations General Assembly. What outcomes would you like to see from the UNGA? Do you think the Millennium Development Goals are achievable by 2015?

Related Content

Transcript: Interview with Dr. Heidi Larson, Executive Director of the aids2031 Project

Heidi LarsonCSIS - We’re here today with Dr. Heidi Larson, Senior Lecturer at the London School for Hygiene and Tropical Medicine, beginning in October, and Executive Director of the aids2301 Project. Dr. Larson thank you so much for joining us today. Dr. Larson I’m wondering if you could begin by describing the origins and objectives of the aids2031 Project?

Dr. Larson – Sure. aids2031 as an idea came about in 2006, which was 25 years of AIDS and I think the world was looking at where we were. The idea for the Project came because a lot of the attention was on the last 25 years and no one was really taking much of a look at the next 25 years. It was also clear that AIDS was going to be with us for a long time. It was an emergency outbreak in the beginning, but it was clear that this was related to kind of shifting response from an emergency to a longer term plan. So that was the birth of it as it were. Then we started to pull together a few people to sort of think through, well, how do we go about that? And UNAIDS launched it but then a number of other funders and partners came on board. And we defined a number of working groups with different angles and themes. It was a pretty decentralized approach, but I think it’s really created a bit of a movement

CSIS - And today you joined us at CSIS to give us a preview of the major findings of aids2031, particularly because you’re launching a book on world AIDS day in December, so the Project is wrapping up. Would you like to tell us about some of the major findings?

Dr. Larson – The book will be called – “AIDS: Taking a long term view,” It’s published by Financial Times Science Press and as you said will come out in December and be launched on world AIDS day.

AIDS is really not over. And the attention to it cannot be over. It’s taking new shapes; we have a lot more information on it; but we recognize that it will not be one single epidemic moving forward; it’s really multiple epidemics around the world, each with their own character –the politics, the economics, and the social drivers are very distinct in different settings. And we’ll have to be much more tailored about responses. We’ll have to be much more efficient. We could do a much better job of using our resources and putting the money where the problems are. We have a lot of evidence that certain countries have not put money where the real issue is for various reasons; sometimes it’s too sensitive, sometimes the information is not there. That’s one of the findings.

It also involves a push. I don’t want to go into all the findings. I’ll just highlight a few and you can look forward to the book in December. A lot of things from the financing perspective, particularly in this economic crisis, is that we need to move away from short, 3-5 year budget horizons to more like 10-20 years. If we’re really going to make a difference we need to think of indicators of success that are not what you can achieve in two years, but what you can achieve and the impact you can have in 10-20 years.

CSIS: Because the aids2031 Project is all about the 25 year time horizon, when you think of that time horizon, what do you think is the biggest challenge the world will face in terms of creating a long term response to HIV? Meeting

Dr. Larson – I think the world’s biggest challenge is not a new challenge – and we haven’t really dealt with it well – and that’s morality, judgment, and stigma. Morality can be a good thing, but I think sometimes the judgment that comes with it has gotten in the way of scientific evidence of what works and what doesn’t. Policies are being made that are perhaps comfortable politically but not effective for the response an in fact, in some cases, have actually contributed to an increase in HIV because people aren’t getting access to the services that they need for prevention. Also in terms of treatment there is still deep discrimination and stigma. We’ve made a lot of progress in some areas, but I think the most difficult things for the world to come to terms with is some of the issues around sexual behavior, around drug use, around marginalization of… marginalized populations both economically and ethnically. There’s a lot of different dynamics of AIDS that make it politically and culturally very sensitive. We need to get past some of those challenges and really look at the importance of saving people’s lives.

CSIS: In today’s discussion you talked about the importance of settings in looking at the response. Could you expand on that thought some? Why are settings so important and what does it mean in tailoring an effective response?

Dr. Larson – One of the things we did in 2031 was a documentary series with BBC World, called “Love in a Time of HIV.” And it followed 5 people living with HIV in 5 different cities: London, New York, St. Petersburg, Johannesburg, and Mumbai. And each of those young people were facing different challenges for what reasons? For some, it was more policies reasons. One discordant couple, for example, one with HIV one without in London were trying to have a baby. And similarly in St. Petersburg [another couple was living with the same situation] and the challenges they faced were quite different from an economic point of view and from a policy point of view – what the government supported and didn’t support. Also from a social acceptance or not point of view, from a cultural point of view. And also in different settings, in South Africa, the key character called Tender, she was in the final stages of – the South African equivalent of American Idol –brilliant voice, a musician. She was the #2 finalist but was cut out [of the competition] because she disclosed her HIV status. The impact HIV can have on your personal, family, professional life varies so differently depending on the setting. And I think we highly underestimate the impact of that… I mean I’m an anthropologist so I have a particular interest and sensitivity to that, but it really does have a profound impact. And when we talk about tailoring the epidemic and tailoring the response, if your epidemic in Russia or Eastern Europe is vastly among drug users and reducing harm among drug users, you don’t put your money into something else. [That’s] an example one setting. If a problem is in one place, you have to understand what the issues are and invest in that area to ensure that you’re really reaching the program where the problem is. Particularly in this difficult economic time you need to be more efficient.

CSIS – Thank you so much for taking the time to sit down and talk with us. Interested listeners can find more information about the aids2301 Project at www.aids2031.org and you can also listen to our full recording or Dr. Larson’s September 16th discussion at CSIS entitled, AIDS 2031 – Looking beyond 2015 and the Millennium Development Goals, at SmartGlobalHealth.org.

Related Content

Report of the CSIS Commission on Smart Global Health Policy

This report marks the culmination of nine months of deliberation by the Commission — a group formed to develop actionable recommendations for a long-term U.S. strategic approach to global health.

We have not answered all the questions that emerged, nor have we devised perfect solutions. But we believe we have put forward a compelling, concrete, and pragmatic plan of action.

Watch the video from this event

Download the Commission Report.

Related Content

H1N1 Influenza and the U.S. Response: Looking Back at 2009

The arrival of the new year has inspired a number of newspapers, magazines, and journals to look back at 2009’s experience with the ongoing swine flu pandemic. Their recent assessments and others can help answer four central questions about H1N1 and the U.S. response.

What is the current situation?

Flu pandemics come in waves. This outbreak’s first wave started in late April and peaked over the summer of 2009. The second wave, which began in August, may now be coming to a close. According to data from Quest Diagnostics, the world’s largest diagnostic testing company, requests for H1N1 tests have fallen 75% since they peaked the week ending October 28. Testing rates are now equivalent to those at the start of the second wave.

Although the CDC transitioned from tracking individual cases of H1N1 on July 24, it continues to estimate H1N1 hospitalizations and deaths. These approximate data indicate that 34 million to 67 million cases of H1N1 occurred between April and mid-November, with 154,000 to 303,000 influenza-related hospitalizations and 7,070 to 13,930 influenza-related deaths. Awful as they are, these numbers are thankfully far below the President’s Council of Advisors on Science and Technology’s August prediction of 30,000 to 90,000 deaths.

The 1918 to 1920 flu pandemic—the archetypal outbreak that killed 50 to 100 million people worldwide—was most dangerous in its later waves, which creates some worry about a third wave of 2009 H1N1. Luckily, however, former Centers for Disease Control and Prevention (CDC) Deputy Director Walter Dowdle and his colleagues, writing in the January 2010 issue of the Mayo Clinic Proceedings, report “no evidence of the evolution of the 2009 H1N1 virus toward a more transmissible or pathogenic phenotype.”

Related Content

⇒ Read More ⇒

Your Responses to the Essay “H1N1 Preparedness”

We've received some very useful and insightful feedback to the essay, H1N1 Preparedness. If you'd like to add your own comments, please read the article and enter your thoughts in the sidebar.

Varnee Murugan - MPH student, Yale School of Public Health

I wholeheartedly agree with the recommendations in this paper. However, I think it is also important not to take too narrow a focus on this issue. Health systems strengthening will be extremely important here and primary health care should not be neglected. By bolstering primary health services, improving governance and mangement, and investing in basic infrastructure, surveillance and laboratory activities will run more effectively and efficiently. Please ensure that pandemic preparedness doesn't become yet another vertical program. If you truly want to think long term, everyone will benefit if there are investments made in health systems strengthening.

Dr. Nosayaba Osazuwa-Peters

The recent H1N1 influenza is a testament to the pestilence of the 21st century.

It also showed however that the earth is a global organism, and so no matter what advances the US or other rich nations make, outbreaks like the H1N1 will continue to affect negatively on earth; directly, through immigration, tourism and other factors, and indirectly through the health economics of the world.

The way forward is simple: Address the issue of health inequalities; devote more attention to preventive medicine research; synthesize a strategy for disaster and pandenmics preparedness.

Again, the Alma-Ata declaration holds the key. If all nations of the earth, spearheaded by the US, can champion the course of Alma-Ata, outbreaks will be better controlled if not totally prevented. So instead of spending all the millions in the world in fashioning new technologies and looking for modern breakthroughs, what will still benefits humanity as a single entity more is sometime truly global: the Alma-Ata way!

Lynn Etheredge - Rapid Learning Project, GW University

The major missing piece that i see in the analysis and recommendations is not in the traditional public health area (prevention, vaccines) but in the US (and world) capacity for "rapid learning" about best  clinical treatments, particularly for  higher risk patients, in a public health emergency.  The limited ability to do "comparative effectiveness research" is a serious problem even for normal medical care issues -- but an acute problem for public health emergencies, e.g. HiN1, where children and have suddenly been found to be much more vulnerable. Rx testing & clinical trials for pediatrics are a serious gap in clinical evidence,  even in the best of circumstances, For H1N1, it has taken HHS many months even to put together a network of ICUs, which needed a new contracting procurement & going through each institution's IRB approval process for participating in research. Even today, 22 million patients & 6 months into the pandemic, there is limited ability to provide guidance on such important issues as use of anti-virals, ventilator use, "double coverage" antibiotic therapy for children with H1N1, asthma & pneumonia, etc. A recent NYTimes op ed (enclosed) highlights the still-unresolved questions about how to assess genetic influence factors in risk (possibly more useful for H1N1  than traditional public health groupings) and treatment. With electronic health records, already for millions of patients in institutions with first-rate health programs (Kaiser-Permanente, Denver Health, Childrens Hospital of Philadelphia, etc.) it would be relatively easy for HHS to design, pre-contract & prepare for rapid-learning  networks about best clinical care in public health emergencies, The US needs to do this & the world also needs such capacities on the front line that can quickly offer better guidance to community physicians, hospitals, and clinics.

To read more comments, please visit this page.

Related Content

Next Page »